VGF: An inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers

Journal of Chemical Neuroanatomy

Volumn 42, Issue 4, 2011, Pages 249-261

  Ferri, Gian Luca ^a   Noli, Barbara ^a   Brancia, Carla ^a   D'Amato, Filomena ^a   Cocco, Cristina ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Biomarker; Homeostasis; Hypothalamus; Neurodegenerative disease; Neuroendocrine; VGF

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; GENE PRODUCT; GENE PRODUCT VGF; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROTROPHIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; BRAIN FUNCTION; BRAIN REGION; CEREBROSPINAL FLUID; DEGENERATIVE DISEASE; DEPRESSION; ENERGY BALANCE; FLUID BALANCE; FOOD INTAKE; GASTROINTESTINAL TRACT; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; IN VITRO STUDY; INSULIN SENSITIVITY; LONG TERM POTENTIATION; MENTAL DISEASE; NERVE STIMULATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PAIN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEOMICS; REPRODUCTION; REVIEW; SENSORY NERVE; SYNAPSE;

ANIMALS; BIOLOGICAL MARKERS; ENDOCRINE SYSTEM DISEASES; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; NERVOUS SYSTEM DISEASES; NEUROPEPTIDES; PROTEIN PRECURSORS; TISSUE DISTRIBUTION;

EID: 80555126802     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2011.05.007     Document Type: Review

References (116)

1. Ahn K., Herman S.B., Fahnoe D.C. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity. Arch. Biochem. Biophys. 1998, 359:258-268.
2. Alder J., Thakker-Varia S., Bangasser D.A., Kuroiwa M., Plummer M.R., Shors T.J., Black I.B. Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J. Neurosci. 2003, 23:10800-10808.
3. Allaman I., Fiumelli H., Magistretti P.J., Martin J.L. Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berl). 2011, (Epub ahead of print).
4. Altar C.A., Laeng P., Jurata L.W., Brockman J.A., Lemire A., Bullard J., Bukhman Y.V., Young T.A., Charles V., Palfreyman M.G. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signalling pathways. J. Neurosci. 2004, 24:2667-2677.
5. Bado A., Levasseur S., Attoub S., Kermorgant S., Laigneau J.P., Bortoluzzi M.N., Moizo L., Lehy T., Guerre-Millo M., Le Marchand-Brustel Y., Lewin M.J. The stomach is a source of leptin. Nature 1998, 394:790-803.
6. Bartolomucci A., La Corte G., Possenti R., Locatelli V., Rigamonti A.E., Torsello A., Bresciani E., Bulgarelli I., Rizzi R., Pavone F., D'Amato F.R., Severini C., Mignogna G., Schininà M.E., Elia G., Brancia C., Ferri G.L., Conti R., Ciani B., Pascucci T., Dell'Omo G., Muller E.E., Levi A., Moles A. TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:14584-14589.
7. Bartolomucci A., Possenti R., Levi A., Pavone F., Moles A. The role of the vgf gene and VGF-derived peptides in nutrition and metabolism. Genes Nutr. 2007, 2:169-180.
8. Bartolomucci A., Bresciani E., Bulgarelli I., Rigamonti A.E., Pascucci T., Levi A., Possenti R., Torsello A., Locatelli V., Muller E.E., Moles A. Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice. Genes Nutr. 2009, 4:49-57.
9. Bernay B., Gaillard M.C., Guryča V., Emadali A., Kuhn L., Bertrand A., Detraz I., Carcenac C., Savasta M., Brouillet E., Garin J., Elalouf J.M. Discovering new bioactive neuropeptides in the striatum secretome using in vivo microdialysis and versatile proteomics. Mol. Cell Proteomics 2009, 8:946-958.
10. Bozdagi O., Rich E., Tronel S., Sadahiro M., Patterson K., Shapiro M.L., Alberini C.M., Huntley G.W., Salton S.R. The neurotrophin-inducibile gene vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J. Neurosci. 2008, 28:9857-9869.
11. Brancia C., Nicolussi P., Cappai P., La Corte G., Possenti R., Ferri G.L. Differential expression and seasonal modulation of VGF peptides in sheep pituitary. J. Endocrinol. 2005, 186:97-107.
12. Brancia C., Cocco C., D'Amato F., Noli B., Sanna F., Possenti R., Argiolas A., Ferri G.L. Selective expression of TLQP-21 and other VGF peptides in gastric neuroendocrine cells and modulation by feeding. J. Endocrinol. 2010, 207:329-341.
13. Canu N., Possenti R., Ricco A.S., Rocchi M., Levi A. Cloning, structural organization analysis, and chromosomal assignment of the human gene for the neurosecretory protein VGF. Genomics 1997, 45:443-446.
14. Carrette O., Demalte I., Scherl A., Yalkinoglu O., Corthals G., Burkhard P., Hochstrasser D.F., Sanchez J.C. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 2003, 3:1486-1494.
15. Cattaneo A., Sesta A., Calabrese F., Nielsen G., Riva M.A., Gennarelli M. The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology 2010, 35:1423-1428.
16. Cheishvili D., Maayan C., Smith Y., Ast G., Razin A. IKAP/hELP1 deficiency in the cerebrum of familial dysautonomia patients results in down regulation of genes involved in oligodendrocyte differentiation and in myelination. Hum. Mol. Genet. 2007, 16:2097-2104.
17. Cirelli C., Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res. 2000, 885:303-321.
18. Cocco C., Brancia C., Pirisi I., D'Amato F., Noli B., Possenti R., Ferri G.L. VGF metabolic-related gene: distribution of its derived peptides in mammalian pancreatic islets. J. Histochem. Cytochem. 2007, 55:619-628.
19. Cocco C., D'Amato F., Noli B., Ledda A., Brancia C., Bongioanni P., Ferri G.L. Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases. J. Anat. 2010, 217:683-693.
20. D'Amato F., Noli B., Brancia C., Cocco C., Flore G., Collu M., Nicolussi P., Ferri G.L. Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation. J. Endocrinol. 2008, 197:359-369.
21. Dmitrieff E.F., Wilson J.T., Dunmire K.B., Bavis R.W. Chronic hyperoxia alters the expression of neurotrophic factors in the carotid body of neonatal rats. Respir. Physiol. Neurobiol. 2011, 175:220-227.
22. Dugas J.C., Tai Y.C., Speed T.P., Ngai J., Barres B.A. Functional genomic analysis of oligodendrocyte differentiation. J. Neurosci. 2006, 26:10967-10983.
23. Eagleson K.L., Fairfull L.D., Salton S.R., Levitt P. Regional differences in neurotrophin availability regulate selective expression of VGF in the developing limbic cortex. J. Neurosci. 2001, 21:9315-9324.
24. Ebling F.J.P., Barrett P. The regulation of seasonal changes in food intake and body weight. J. Neuroendocrinol. 2008, 20:827-833.
25. Emoto N., Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J. Biol. Chem. 1995, 270:15262-15268.
26. Ferri G.L., Levi A., Possenti R. A novel neuroendocrine gene product: selective VGF8a gene expression and immuno-localisation of the VGF protein in endocrine and neuronal populations. Mol. Brain Res. 1992, 13:139-143.
27. Ferri G.L., Gaudio R.M., Cossu M., Rinaldi A.M., Polak J.M., Berger P., Possenti R. The " VGF" protein in rat adenohypophysis: sex differences and changes during the estrous cycle and after gonadectomy. Endocrinology 1995, 136:2244-2251.
28. Ferri G.L., Tirolo C., Atzori L., Brizi E., Neuhuber W., Terenghi G., Possenti R., Rende M. The neurotrophin-inducible protein " VGF" in sensory afferents and spinal cord. Soc. Neurosci. Abstracts 1997, 23(part 2):1259. (USA).
29. Fricker L.D. Carboxypeptidase E. Handbook of Proteolytic Enzymes 2004, 840-844. Academic Press, San Diego, CA. A.J. Barrett, N.D. Rawlings, J.F. Woessner (Eds.).
30. Fricker L.D. Metallocarboxypeptidase D. Handbook of Proteolytic Enzymes 2004, 848-851. Academic Press, San Diego, CA. A.J. Barrett, N.D. Rawlings, J.F. Woessner (Eds.).
31. Funkelstein L., Toneff T., Hwang S.R., Reinheckel T., Peters C., Hook V. Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression. J. Neurochem. 2008, 106:384-391.
32. Funkelstein L., Toneff T., Mosier C., Hwang S.R., Beuschlein F., Lichtenauer U.D., Reinheckel T., Peters C., Hook V. Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrate by protease gene knockout and expression. J. Biol. Chem. 2008, 283:35652-35659.
33. Girgenti M.J., Hunsberger J., Duman C.H., Sathyanesan M., Terwilliger R., Newton S.S. Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects. Biol. Psychiatry 2009, 66:267-274.
34. Hahm S., Mizuno T.M., Wu T.I., Wisor J.P., Priest C.A., Kozac C.A., Boozer C.N., Peng B., McEvoy R.C., Good P., Kelley K.A., Takahashi J.S., Pintar J.E., Roberts J.L., Mobbs C.V., Salton S.R.J. Targeted deletion of the vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron 1999, 23:537-548.
35. Hahm S., Fekete C., Mizuno T.M., Windsor J., Yan H., Boozer C.N., Lee C., Elmquist J.K., Lechan R.M., Mobbs C.V., Salton S.R.J. VGF is required for obesity induced by diet, gold thioglucose treatment, and Agouti and is differentially regulated in pro-opiomelanocortin-and neuropeptide Y-containing arcuate neurons in response to fasting. J. Neurosci. 2002, 22:6929-6938.
36. Helle K.B. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biol. Rev. 2004, 79:769-794.
37. Hernández-Vargas H., Rodríguez-Pinilla S.M., Julián-Tendero M., Sánchez-Rovira P., Cuevas C., Antón A., Ríos M.J., Palacios J., Moreno-Bueno G. Gene expression profiling of breast cancer cells in response to gemcitabine: NF-KappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res. Treat. 2006, 102:157-172.
38. Hook V.Y.H. Protease pathways in peptide neurotransmission and neurodegenerative disease. Cell. Mol. Neurobiol. 2006, 26:449-469.
39. Hook V., Funkelstein L., Lu D., Bark S., Wegrzyn J., Hwang S.R. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annu. Rev. Pharmacol. Toxicol. 2008, 48:393-423.
40. Haung J.T., Leweke F.M., Oxley D., Wang L., Harris N., Koethe D., Gerth C.W., Nolden B.M., Gross S., Schreiber D., Reed B., Bahn S. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PloS Med. 2006, 3:e428.
41. Huang J.T., Leweke F.M., Tsang T.M., Koethe D., Kranaster L., Gerth C.W., Gross S., Schreiber D., Ruhrmann S., Schultze-Lutter F., Klosterkötter J., Holmes E., Bahn S. CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS One 2007, 2:e756.
42. Hunsberger J.G., Newton S.S., Bennett A.H., Duman C.H., Russell D.S., Salton S.R., Duman R.S. Antidepressant actions of the exercise-regulated gene VGF. Nat. Med. 2007, 13:1476-1482.
43. Hwang S.R., Garza C., Mosier C., Toneff T., Wunderlich E., Goldsmith P., Hook V. Cathepsin L expression is directed to secretory vesicles for enkephalin neuropeptide biosynthesis and secretion. J. Biol. Chem. 2007, 282:9556-9563.
44. Hwang S.R., O'Neill A., Bark S., Foulon T., Hook V. Secretory vesicle aminopeptidase B related to neuropeptide processing: molecular identification and subcellular localization to enkephalin- and NPY-containing chromaffin granules. J. Neurochem. 2007, 100:1340-1350.
45. Jethwa P.H., Warner A., Nilaweera K.N., Brameld J.M., Keyte J.W., Carter W.G., Bolton N., Bruggraber M., Morgan P.J., Barrett P., Ebling F.J.P. VGF-derived peptide, TLQP-21, regulates food intake and body weight in siberian hamsters. Endocrinology 2007, 148:4044-4055.
46. Jethwa P.H., Ebling F.J.P. Role of VGF-derived peptides in the control of food intake, body weight and reproduction. Neuroendocrinology 2008, 88:80-87.
47. Kanemasa K., Okamura H., Kodama T., Ibata Y. Induction of VGF mRNA in neurons of the rat nucleus tractus solitarius and the dorsal motor nucleus of vagus in duodenal ulceration by cysteamine. Brain Res. Mol. Brain Res. 1995, 32:55-62.
48. Levi A., Eldridge J.D., Paterson B.M. Molecular cloning of a gene sequence regulated by nerve growth factor. Science 1985, 229:393-395.
49. Levi A., Ferri G.L., Watson E., Possenti R., Salton S.R. Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor. Cell. Mol. Neurobiol. 2004, 24:517-533.
50. Li L., Suzuki T., Mori N., Greengard P. Identification of a functional silencer element involved in neuron-specific expression of the synapsin I gene. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:1460-1464.
51. Lim J., Berezniuk I., Che F.Y., Parikh R., Biswas R., Pan H., Fricker L.D. Altered neuropeptide processing in prefrontal cortex of Cpe (fat/fat) mice: implications for neuropeptide discovery. J. Neurochem. 2006, 96:1169-1181.
52. Liu J.W., Andrews P.C., Mershon J.L., Yan C., Allen D.L., Ben-Jonathan N. Peptide V: a VGF-derived neuropeptide purified from bovine posterior pituitary. Endocrinology 1994, 135:2742-2748.
53. Liu Z.F., Chen C.Y., Tang W., Zhang J.Y., Gong Y.Q., Jia J.H. Gene-expression profiles in gastric epithelial cells stimulated with spiral and coccoid Helicobacter pylori. J. Med. Microbiol. 2006, 55:1009-1015.
54. Lombardo A., Rabacchi S.A., Cremisi F., Pizzorusso T., Cenni M.C., Possenti R., Barsacchi G., Maffei L. A developmentally regulated nerve growth factor-induced gene, VGF, is expressed in geniculocortical afferents during synaptogenesis. Neuroscience 1995, 65:997-1008.
55. Mahata S.K., Mahata M., Fischer-Colbrie R., Winkler H. In situ hybridization: mRNA levels of secretogranin II, VGF and peptidylglycine alpha-amidating monooxygenase in brain of salt-loaded rats. Histochemistry 1993, 99:287-293.
56. Mahata S.K., Mahata M., Hörtnag H., Fischer-Colbrie R., Steiner H.J., Dietze O., Winkler H. Concomitant changes of messenger ribonucleic acid levels of secretogranin II, VGF, vasopressin and oxytocin in the paraventricular nucleus of rats after adrenalectomy and during lactation. J. Neuroendocrinol. 1993, 5:323-330.
57. Matsuo T., Yamaguchi H., Kageyama H., Sasaki K., Shioda S., Minamino N., Nakazato M. Localization of neuroendocrine regulatory peptide-1 and-2 in human tissues. Regul. Pept. 2010, 163:43-48.
58. Mishiro-Sato E., Sasaki K., Matsuo T., Kageyama H., Yamaguchi H., Date Y., Matsubara M., Ishizu T., Yoshizawa-Kumagaye K., Satomi Y., Takao T., Shioda S., Nakazato M., Minamino N. Distribution of neuroendocrine regulatory peptide-1 and -2, and proteolytic processing of their precursor VGF protein in the rat. J. Neurochem. 2010, 114:1097-1106.
59. Mitra A., Fillmore R.A., Metge B.J., Rajesh M., Xi Y., King J., Ju J., Pannell L., Shevde L.A., Samant R.S. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res. 2008, 10:R22.
60. Moss A., Ingram R., Koch S., Theodorou A., Low L., Baccei M., Hathway G.J., Costigan M., Salton S.R., Fitzgerald M. Mol. Pain 2008, 4:62.
61. Mzhavia N., Pan H., Che F.Y., Fricker L.D., Devi L.A. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides. J. Biol. Chem. 2003, 278:14704-14711.
62. Newton S.S., Collier E.F., Husberger J., Adams D., Terwilliger R., Selvanayagam E., Duman R.S. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J. Neurosci. 2003, 23:10841-10851.
63. Okamura H., Tanaka M., Kanemasa K., Ban Y., Inouye S.T., Ibata Y. In situ hybridization histochemistry of vgf mRNA in the rat suprachiasmatic nucleus: co-localization with vasopressin/neurophysin and VIP/PHI. Neurosci. Lett. 1995, 189:181-184a.
64. Ostrow K.L., Park H.L., Hoque M.O., Kim M.S., Liu J., Argani P., Westra W., Van Criekinge W., Sidransky D. Pharmacologic unmasking of epigenetically silenced genes in breast cancer. Clin. Cancer Res. 2009, 15:1184-1191.
65. Pan H., Nanno D., Che F.Y., Zhu X., Salton S.R., Steiner D.F., Fricker L.D., Devi L.A. Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry 2005, 44:4939-4948.
66. Pan H., Che F.Y., Peng B., Steiner D.F., Pintar J.E., Fricker L.D. The role of prohormone convertase-2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic study. J. Neurochem. 2006, 98:1763-1777.
67. Pasinetti G.M., Ungar L.H., Lange D.J., Yemul S., Deng H., Yuan X., Brown R.H., Cudkowicz M.E., Newhall K., Peskind E., Marcus S., Ho L. Identification of potential CSF biomarkers in ALS. Neurology 2006, 66:1218-1222.
68. Piccioli P., Di Luzio A., Amann R., Schuligoi R., Surani M.A., Donnerer J., Cattaneo A. Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice. Neuron 1995, 15:373-384.
69. Pinilla L., Pineda R., Gaytan F., Romero M., Garcia-Galiano D., Sanchez-Garrido M.A., Ruiz-Pino F., Tena-Sempere M., Aguilar E. Characterization of the reproductive effects of the anorexigenic VGF-derived peptide, TLQP-21: in vivo and in vitro studies in male rats. Am. J. Physiol. Endocrinol. Metab. 2011, (Epub ahead of print).
70. Possenti R., Eldridge J.D., Paterson B.M., Grasso A., Levi A. A protein induced by NGF in PC12 cells is stored in secretory vesicles and released through the regulated pathway. EMBO J. 1989, 8:2217-2223.
71. Possenti R., Di Rocco G., Nasi S., Levi A. Regulatory elements in the promoter region of vgf, a nerve growth factor-inducible gene. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:3815-3819.
72. Possenti R., Rinaldi A.M., Ferri G.L., Borboni P., Trani E., Levi A. Expression, processing, and secretion of the neuroendocrine VGF peptides by INS-1 cells. Endocrinology 1999, 140:3727-3735.
73. Prigge S.T., Mains R.E., Eipper B.A., Amzel L.M. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell. Mol. Life Sci. 2000, 57:1236-1259.
74. Riedl M.S., Braun P.D., Kitto K.F., Roiko S.A., Anderson L.B., Honda C.N., Fairbanks C.A., Vulchanova L. Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing. J. Neurosci. 2009, 29:13377-13388.
75. Rindi G., Licini L., Necchi V., Bottarelli L., Campanini N., Azzoni C., Favret M., Giordano G., D'Amato F., Brancia C., Solcia E., Ferri G.L. Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development and increase in hyperplasia and neoplasia. J. Clin. Endocrinol. Metab. 2007, 92:2811-2815.
76. Rizzi R., Bartolomucci A., Moles A., D'Amato F., Sacerdote P., Levi A., La Corte G., Ciotti M.T., Possenti R., Pavone F. The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain. Neurosci. Lett. 2008, 441:129-133.
77. Rüetschi U., Zetterberg H., Podust V.N., Gottfries J., Li S., Hviid Simonsen A., McGuire J., Karlsson M., Rymo L., Davies H., Minthon L., Blennow K. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp. Neurol. 2005, 196:273-281.
78. Rouille Y., Duguay S.J., Lund K., Furuta M., Gong Q., Lipkind G., Oliva A.A., Chan S.J., Steiner D.F. Proteolytic processing mechanisms in the biosyntesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front. Neuro-endocrinol. 1995, 16:322-361.
79. Salton S.R.J., Ferri G.L., Hahm S., Snyder S.E., Wilson A.J., Possenti R., Levi A. VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance. Front. Neuroendocrinol. 2000, 21:199-219.
80. Sasaki K., Takahashi N., Satoh M., Yamasaki M., Minamino N. A peptidomics strategy for discovering endogenous bioactive peptides. J. Proteome Res. 2010, 9:5047-5052.
81. Seidah N.G., Chretien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 1999, 848:45-62.
82. Seidah N.G., Chretien M. Proprotein convertase 2. Handbook of Proteolitic Enzymes 2004, 1865-1868. Academic Press, San Diego. A.J. Barrett, N.D. Rawling, J.F. Woessner (Eds.).
83. Seidah N.G., Chretien M. Proprotein convertase 1. Handbook of Proteolitic Enzymes 2004, 1861-1865. Academic Press, San Diego. A.J. Barrett, N.D. Rawling, J.F. Woessner (Eds.).
84. Selle H., Lamerz J., Buerger K., Dessauer A., Hager K., Hampel H., Karl J., Kellmann M., Lannfelt L., Louhija J., Riepe M., Rollinger W., Tumani H., Schrader M., Zucht H.D. Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease. Comb. Chem. High Throughput Screen 2005, 8:801-806.
85. Severini C., Ciotti M.T., Biondini L., Quaresima S., Rinaldi A.M., Levi A., Frank C., Possenti R. TLQP-21, a neuroendocrine VGF-derived pepdide, prevents cerebellar granule cells death induced by serum and potassium deprivation. J. Neurochem. 2008, 104:534-544.
86. Severini C., La Corte G., Improta G., Broccardo M., Agostini S., Petrella C., Sibilia V., Pagani F., Guidobono F., Bulgarelli I., Ferri G.L., Brancia C., Rinaldi A.M., Levi A., Possenti R. In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions. Br. J. Pharmacol. 2009, 157:984-993.
87. Shimazawa M., Tanaka H., Ito Y., Morimoto N., Tsuruma K., Kadokura M., Tamura S., Inoue T., Yamada M., Takahashi H., Warita H., Aoki M., Hara H. An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS. PloS One 2010, 5:e15307.
88. Sibilia V., Pagani F., Bulgarelli I., Mrak E., Broccardo M., Improta G., Severini C., Possenti R., Guidobono F. TLQP-21, a VGF-derived peptide, prevents ethanol-induced gastric lesions: insights into its mode of action. Neuroendocrinology 2010, 92:189-197.
89. Sibilia V., Pagani F., Bulgarelli I., Tulipano G., Possenti R., Guidobono F. Characterization of the mechanisms involved in the gastric antisecretory effect of TLQP-21, a vgf-derived peptide, in rats. Amino Acids 2010, (December). (Epub ahead of print).
90. Snyder S.E., Salton S.R. Expression of VGF mRNA in the adult rat central nervous system. J. Comp. Neurol. 1998, 394:91-105.
91. Snyder S.E., Pintar J.E., Salton S.R. Developmental expression of VGF mRNA in the prenatal and postnatal rat. J. Comp. Neurol. 1998, 394:64-90.
92. Snyder S.E., Cheng H.W., Murray K.D., Isackson P.J., McNeill T.H., Salton S.R. The messenger RNA encoding VGF, a neuronal peptide precursor, is rapidly regulated in the rat central nervous system by neuronal activity, seizure and lesion. Neuroscience 1998, 82:7-19.
93. Snyder S.E., Peng B., Pintar J.E., Salton S.R. Expression of VGF mRNA in developing neuroendocrine and endocrine tissues. J. Endocrinol. 2003, 179:227-235.
94. Stark M., Danielsson O., Griffiths W.J., Jörnvall H., Johansson J. Peptide repertoire of human cerebrospinal fluid: novel proteolytic fragments of neuroendocrine proteins. J. Chromatogr. B. Biomed. Sci. Appl. 2001, 754:357-367.
95. Steiner D.F. The proprotein convertases. Curr. Opin. Chem. Biol. 1998, 2:31-39.
96. Succu S., Cocco C., Mascia M.S., Melis T., Melis M.R., Possenti R., Levi A., Ferri G.L., Argiolas A. Pro-VGF-derived peptides induce penile erection in male rats: possible involvement of oxytocin. Eur. J. Neurosci. 2004, 20:3035-3040.
97. Succu S., Mascia M.S., Melis T., Sanna F., Melis M.R., Possenti R., Argiolas A. Pro-VGF-derived peptides induce penile erection in male rats: involvement of paraventricular nitric oxide. Neuropharmacology 2005, 49:1017-1025.
98. Susaki E., Wang G., Cao G., Wang H.Q., Englander E.W., Greeley G.H. Apelin cells in the rat stomach. Regul. Pept. 2005, 129:37-41.
99. Thakker-Varia S., Krol J.J., Nettleton J., Bilimoria P.M., Bangasser D.A., Shors T.J., Black I.B., Alder J. The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J. Neurosci. 2007, 27:12156-12167.
100. Thakker-Varia S., Jean Y.Y., Parikh P., Sizer C.F., Jernstedt Ayer J., Parikh A., Hyde T.M., Buyske S., Alder J. The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithium. J. Neurosci. 2010, 30:9368-9380.
101. Toshinai K., Yamaguchi H., Kageyama H., Matsuo T., Koshinaka K., Sasaki K., Shioda S., Minamino N., Nakazato M. Neuroendocrine regulatory peptide-2 regulates feeding behavior via the orexin system in the hypothalamus. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E394-401.
102. Trani E., Ciotti T., Rinaldi A.M., Canu N., Ferri G.L., Levi A., Possenti R. Tissue-specific processing of the neuroendocrine protein VGF. J. Neurochem. 1995, 65:2441-2449.
103. Trani E., Giorgi A., Canu N., Amadoro G., Rinaldi A.M., Halban P.A., Ferri G.L., Possenti R., Schininà M.E., Levi A. Isolation and characterization of VGF peptides in rat brain. Role of PC1/3 and PC2 in the maturation of VGF precursor. J. Neurochem. 2002, 81:565-574.
104. van den Pol A.N., Decavel C., Levi A., Paterson B. Hypothalamic expression of a novel gene product, VGF: immunocytochemical analysis. J. Neurosci. 1989, 9:4122-4137.
105. van den Pol A.N., Bina K., Decavel C., Ghosh P. VGF expression in the brain. J. Comp. Neurol. 1994, 347:455-469.
106. Wardman J.H., Zhang X., Gagnon S., Castro L.M., Zhu X., Steiner D.F., Day R., Fricker L.D. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics. J. Neurochem. 2010, 114:215-225.
107. Watson E., Hahm S., Mizuno T.M., Windsor J., Montgomery C., Scherer P.E., Mobbs C.V., Salton S.R. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Endocrinology 2005, 146:5151-5163.
108. Watson E., Fargali S., Okamoto H., Sadahiro M., Gordon R.E., Chakraborty T., Sleeman M.W., Salton S.R. Analysis of knockout mice suggests a role for VGF in the control of fat storage and energy expenditure. BMC Physiol. 2009, 28:9-19.
109. Wisor J.P., Takahashi J.S. Regulation of the vgf gene in the golden hamster suprachiasmatic nucleus by light and by circadian clock. J. Comp. Neurol. 1997, 378:229-238.
110. Xia W., Mruk D.D., Lee W.M., Cheng C.Y. Unraveling the molecular targets pertinent to junction restructuring events during spermatogenesis using the Adjudin-induced germ cell depletion model. J. Endocrinol. 2007, 192:563-583.
111. Yamaguchi H., Sasaki K., Satomi Y., Shimbara T., Kageyama H., Mondal M.S., Toshinai K., Date Y., González L.J., Shioda S., Takao T., Nakazato M., Minamino N. Peptidomic identification and biological validation of neuroendocrine regulatory peptide-1 and -2. J. Biol. Chem. 2007, 282:26354-26360.
112. Yuan X., Desiderio D.M. Human cerebrospinal fluid peptidomics. J. Mass Spectrom. 2005, 40:176-181.
113. Zhang X., Che F.Y., Berezniuk I., Sonmez K., Toll L., Fricker L.D. Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processing. J. Neurochem. 2008, 107:1596-1613.
114. Zhang X., Pan H., Peng B., Steiner D.F., Pintar J.E., Fricker L.D. Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis. J. Neurochem. 2010, 112:1168-1179.
115. Zhao Z., Lange D.J., Ho L., Bonini S., Shao B., Salton S.R., Thomas S., Pasinetti G.M. VGF is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis. Int. J. Med. Sci. 2008, 5:92-99.
116. Zhou A., Webb G., Zhu X., Steiner D.F. Proteolytic processing in the secretory pathway. J. Biol. Chem. 1999, 274:20745-20748.